|
ICMT expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.77739999571858E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.5698000000185E-06 |
| Normal-vs-Stage2 |
2.02319999642597E-08 |
| Normal-vs-Stage3 |
1.85018999999675E-05 |
| Normal-vs-Stage4 |
5.681500E-03 |
| Stage1-vs-Stage2 |
2.216100E-02 |
| Stage1-vs-Stage3 |
1.212790E-01 |
| Stage1-vs-Stage4 |
2.641000E-01 |
| Stage2-vs-Stage3 |
3.894800E-01 |
| Stage2-vs-Stage4 |
5.612400E-01 |
| Stage3-vs-Stage4 |
9.135400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.89949999951367E-07 |
| Normal-vs-AfricanAmerican |
2.68019999971614E-07 |
| Normal-vs-Asian |
9.63630000000437E-05 |
| Caucasian-vs-AfricanAmerican |
4.552800E-01 |
| Caucasian-vs-Asian |
1.985450E-01 |
| AfricanAmerican-vs-Asian |
2.398800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.97499999582607E-08 |
| Normal-vs-Female |
3.982700E-04 |
| Male-vs-Female |
3.130800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.08660000009264E-07 |
| Normal-vs-Extreme_Weight |
6.14529999998226E-07 |
| Normal-vs-Obese |
5.52200000000225E-05 |
| Normal-vs-Extreme_Obese |
5.575800E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.680400E-01 |
| Normal_Weight-vs-Obese |
2.927200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.962200E-01 |
| Extreme_Weight-vs-Obese |
6.679200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.929800E-01 |
| Obese-vs-Extreme_Obese |
8.281400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.952800E-04 |
| Normal-vs-Age(41-60Yrs) |
2.01869999999493E-05 |
| Normal-vs-Age(61-80Yrs) |
2.36610000481363E-08 |
| Normal-vs-Age(81-100Yrs) |
2.233900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.805800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.636400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.920600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.219040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.538000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.094600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.68876999999679E-05 |
| Normal-VS-Type2 PRCC |
2.20620000046523E-08 |
| Normal-VS-KIRP CIMP |
3.730100E-02 |
| Normal-VS-Unclassified PRCC |
1.003550E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.200300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.517800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.744600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.027200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.700170E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.543200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.02359995216517E-09 |
| Normal-vs-N1 |
5.93030002882244E-09 |
| Normal-vs-N2 |
6.315200E-01 |
| N0-vs-N1 |
7.625400E-01 |
| N0-vs-N2 |
1.610360E-01 |
| N1-vs-N2 |
3.604800E-01 |
|
|
